Mavacoxib
CAS: 170569-88-7
Rif. 3D-FM102826
| 5mg | Fuori produzione | ||
| 10mg | Fuori produzione | ||
| 25mg | Fuori produzione |
Informazioni sul prodotto
Nome:
Mavacoxib
Sinonimi:
- 4-(5-(4-Fluorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide
- Benzenesulfonamide, 4-(5-(4-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)-
- Mavacoxib [USAN]
- Pha 739,521
- Trocoxil
- Unii-Yft7X7Sr77
Descrizione:
Mavacoxib is a nonsteroidal anti-inflammatory drug that inhibits the synthesis of prostaglandins. It has been shown to be effective in the treatment of pain, inflammation, and fever. Mavacoxib has been studied for its potential use as an anticancer agent. In vitro studies have demonstrated that mavacoxib inhibits the growth of cancer cells and induces apoptosis at concentrations below those required for inhibition of cyclooxygenase. The mechanism of action is not fully understood but may involve inhibition of DNA synthesis and cell cycle progression. Mavacoxib has shown antimicrobial resistance in some bacterial strains due to its inability to bind to the active site on bacterial enzymes.
Avviso:
I nostri prodotti sono destinati esclusivamente ad uso di laboratorio. Per qualsiasi altro utilizzo, vi preghiamo di contattarci.
Marchio:
Biosynth
Conservazione lunga:
Note:
Proprietà chimiche
Peso molecolare:
385.34 g/mol
Formula:
C16H11F4N3O2S
Purezza:
Min. 95%
MDL:
Punto di fusione:
Punto di ebollizione:
Punto di infiammabilità:
Densità:
Concentrazione:
EINECS:
Merck:
Codice SA:
